Aptinyx (APTX) News Today → The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad) Free APTX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock AnalysisEarningsInsider TradesOwnershipSocial MediaStock AnalysisEarningsInsider TradesOwnershipSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineNew Leaf Venture Management III, L.L.C.'s Net Worthbenzinga.com - March 12 at 2:02 PMPatrick J Heron's Net Worthbenzinga.com - February 9 at 8:57 PMBest Noise-Canceling Headphones for 2024cnet.com - January 13 at 3:17 PMAptinyx Inc APTXmorningstar.com - December 17 at 11:10 PMNorth American Morning Briefing: Concerns About -2-morningstar.com - September 7 at 12:18 PMHere's Why Aptinyx Inc. (APTX) Is a Great 'Buy the Bottom' Stock Nowfinance.yahoo.com - March 30 at 3:35 PMAptinyx Reports Results from Phase 2 Study of NYX-458 in Cognitive Impairment Associated with Parkinson's Disease and Dementia with Lewy Bodies and Provides Pipeline and Corporate Updatefinance.yahoo.com - February 27 at 6:11 PMmarketbeat.com - February 27 at 4:06 PMAptinyx to Present at the SVB Securities Global Biopharma Conferencefinance.yahoo.com - January 31 at 9:38 AMAptinyx Inc. (APTX) Stock Historical Prices & Data - Yahoo Financeca.finance.yahoo.com - January 16 at 6:12 PMAptinyx (NASDAQ: APTX)fool.com - January 5 at 6:03 AMAptinyx Inc. (NASDAQ:APTX) Q3 2022 Earnings Call Transcriptinsidermonkey.com - December 30 at 1:12 AMH.C. Wainwright Keeps Their Buy Rating on Aptinyx (APTX)markets.businessinsider.com - December 12 at 6:32 PMAptinyx Reports Third Quarter 2022 Financial Results and Recent Highlightsfinance.yahoo.com - November 8 at 4:23 PMAptinyx Inc. (NASDAQ: APTX)fool.com - October 30 at 5:26 PMAptinyx to Report Third Quarter 2022 Financial Results on Tuesday, November 8, 2022finance.yahoo.com - October 18 at 11:17 AMAPTX.OQ - Aptinyx Inc | Stock Price & Latest News | Reutersreuters.com - October 2 at 12:57 AMAptinyx Inc. (APTX)finance.yahoo.com - September 24 at 6:11 PMHopeful week for insiders who might be regretting buying US$567k of Aptinyx Inc. (NASDAQ:APTX) stock earlier this year - Nasdaqnasdaq.com - September 12 at 5:10 PMHC Wainwright Adjusts Price Target on Aptinyx to $1 From $2, Reiterates Buy Rating - Marketscreener.commarketscreener.com - August 26 at 5:03 PMAptinyx Completes Enrollment in Phase 2 Study of NYX-458 in Cognitive Impairment Associated with Parkinson's Disease and Dementia with Lewy Bodies - Business Wirebusinesswire.com - August 25 at 9:25 AMAptinyx Completes Enrollment in Phase 2 Study of NYX-458 in Cognitive Impairment Associated with Parkinson’s Disease and Dementia with Lewy Bodiesfinance.yahoo.com - August 25 at 9:24 AMBullish Aptinyx Inc. (NASDAQ:APTX) investors are yet to receive a pay off on their US$567k betfinance.yahoo.com - August 22 at 11:31 AMBiotech Stock Roundup: GILD's Drug News, NVAX & MRNA COVID-19 Vaccine Updates - Nasdaqnasdaq.com - August 19 at 10:06 PMNorth American Morning Briefing: Investors Seek -2- - Morningstarmorningstar.com - August 17 at 11:45 AMWhat 4 Analyst Ratings Have To Say About Aptinyxmarkets.businessinsider.com - August 16 at 1:23 PMTruist Downgrades Aptinyx to Hold From Buy - Marketscreener.commarketscreener.com - August 15 at 9:55 PMRecap Of Friday’s Biotech Catalysts - End Of the Day Summary - Benzingabenzinga.com - August 12 at 11:15 PMAptinyx: Fibromyalgia-Pain Drug Trial Misses Endpoints - MarketWatchmarketwatch.com - August 12 at 6:14 PMAptinyx's Chronic Pain Candidate Fails To Top Placebo In Mid-Stage Studyfinance.yahoo.com - August 12 at 1:14 PMAptinyx Reports Results from Phase 2b Study of NYX-2925 in Fibromyalgia - Business Wirebusinesswire.com - August 12 at 7:36 AMAptinyx Reports Results from Phase 2b Study of NYX-2925 in Fibromyalgiafinance.yahoo.com - August 12 at 7:36 AMmarketbeat.com - August 12 at 7:10 AMAptinyx Inc. (APTX) Q2 2022 Earnings Call Transcript - The Motley Foolfool.com - August 6 at 8:51 AMAptinyx Inc. (APTX) Q2 2022 Earnings Call Transcriptfool.com - August 6 at 5:08 AMAptinyx Reports Second Quarter 2022 Financial Results and Recent Highlights - Yahoo Financefinance.yahoo.com - August 5 at 10:50 PMAptinyx GAAP EPS of -$0.26 beats by $0.02 (NASDAQ:APTX) - Seeking Alphaseekingalpha.com - August 4 at 9:43 PMAptinyx Reports Second Quarter 2022 Financial Results and Recent Highlights - Business Wirebusinesswire.com - August 4 at 4:43 PMAptinyx to Report Second Quart - GuruFocus.comgurufocus.com - July 16 at 9:38 AMAptinyx to Report Second Quarter 2022 Financial Results on Thursday, August 4, 2022finance.yahoo.com - July 15 at 8:15 AMU.S. Silica (SLCA) Wraps Up $100 Million Loan Repurchase - Nasdaqnasdaq.com - July 13 at 11:38 PMTFII vs. CHRW: Which Stock Should Value Investors Buy Now? - Nasdaqnasdaq.com - July 13 at 11:38 PMAll You Need to Know About Aptinyx Inc. (APTX) Rating Upgrade to Buy - Nasdaqnasdaq.com - July 13 at 6:37 PMPhilips (PHG) Expands AI Portfolio With SmartSpeed Solution - Nasdaqnasdaq.com - July 13 at 6:37 PMAmerica Movil (AMX) Q2 Earnings Decline Y/Y, Revenues Increase - Nasdaqnasdaq.com - July 13 at 1:37 PMMGM Resorts (MGM) Announces Partnership With MLB Players - Nasdaqnasdaq.com - July 13 at 1:37 PMAptinyx to Participate in H.C. Wainwright 1st Annual Mental Health Conferencefinance.yahoo.com - June 22 at 12:36 PMAPTINYX INC. : Submission of Matters to a Vote of Security Holders (form 8-K) - Marketscreener.commarketscreener.com - May 31 at 8:24 PMAptinyx : Statement of Changes in Beneficial Ownership (Form 4) - Marketscreener.commarketscreener.com - May 31 at 8:24 PMCIPN Market: 5.4% CAGR for Chemotherapy-Induced Peripheral Neuropathy Market Worth $1.17 Billion, Globally, by 2028: The Insight Partners - GlobeNewswireglobenewswire.com - May 27 at 5:00 AM Get Aptinyx News Delivered to You Automatically Sign up to receive the latest news and ratings for APTX and its competitors with MarketBeat's FREE daily newsletter. Email Address The “Perfect Storm” for Gold (Ad)Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025. Click here now to download the free Precious Metals Buying Guide! APTX Media Mentions By Week APTX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. APTX News Sentiment▼0.000.52▲Average Medical News Sentiment APTX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. APTX Articles This Week▼00▲APTX Articles Average Week Get Aptinyx News Delivered to You Automatically Sign up to receive the latest news and ratings for APTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Context Therapeutics News Grifols News LAVA Therapeutics News Mainz Biomed News NLS Pharmaceutics News Pharvaris News Procaps Group News Qilian International Holding Group News Tiziana Life Sciences News Aclarion News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:APTX) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTIHe Is Giving Away BitcoinCrypto Swap ProfitsSHOCKING Crypto Leak…Crypto 101 MediaThe #1 Crypto for 2024InvestorPlaceHow Biden has already won 2024Porter & CompanyUrgent alert: open this for a huge profit potentialTimothy SykesMy biggest AI fearParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aptinyx Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.